Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 191 entries
Sorted by: Best Match Show Resources per page
Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention.

Open heart

Wall JJS, Iqbal J, Andrews M, Teare D, Ghobrial M, Hinton T, Turton S, Quffa L, El-Omar M, Fraser DG, Siotia A, Gunn J.
PMID: 28878944
Open Heart. 2017 Jul 25;4(2):e000576. doi: 10.1136/openhrt-2016-000576. eCollection 2017.

OBJECTIVE: To develop and validate a contemporary clinical risk score to predict mortality after percutaneous coronary intervention (PCI).METHODS: Using data collected from patients undergoing PCI at the South Yorkshire Cardiothoracic Centre, Sheffield, UK, between January 2007 and September 2013,...

Cite
Wall JJS, Iqbal J, Andrews M, et al. Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention. Open Heart. 2017;4(2):e000576doi: 10.1136/openhrt-2016-000576.
Wall, J. J. S., Iqbal, J., Andrews, M., Teare, D., Ghobrial, M., Hinton, T., Turton, S., Quffa, L., El-Omar, M., Fraser, D. G., Siotia, A., & Gunn, J. (2017). Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention. Open heart, 4(2), e000576. https://doi.org/10.1136/openhrt-2016-000576
Wall, Joshua J S, et al. "Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention." Open heart vol. 4,2 (2017): e000576. doi: https://doi.org/10.1136/openhrt-2016-000576
Wall JJS, Iqbal J, Andrews M, Teare D, Ghobrial M, Hinton T, Turton S, Quffa L, El-Omar M, Fraser DG, Siotia A, Gunn J. Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention. Open Heart. 2017 Jul 25;4(2):e000576. doi: 10.1136/openhrt-2016-000576. eCollection 2017. PMID: 28878944; PMCID: PMC5574428.
Copy Download .nbib Format: NLM
Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Al-Turki DA, Al-Omar MA, Abou-Zeid LA, Shehata IA, Al-Awady MS.
PMID: 28223863
Saudi Pharm J. 2017 Jan;25(1):59-69. doi: 10.1016/j.jsps.2015.07.001. Epub 2015 Jul 26.

New series of 3,4-diaryl-2-thioxoimidazolidin-4-ones and 3-alkylthio-4,5-diaryl-4

Cite
Al-Turki DA, Al-Omar MA, Abou-Zeid LA, et al. Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors. Saudi Pharm J. 2015;25(1):59-69doi: 10.1016/j.jsps.2015.07.001.
Al-Turki, D. A., Al-Omar, M. A., Abou-Zeid, L. A., Shehata, I. A., & Al-Awady, M. S. (2017). Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 25(1), 59-69. https://doi.org/10.1016/j.jsps.2015.07.001
Al-Turki, Deema A, et al. "Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 25,1 (2017): 59-69. doi: https://doi.org/10.1016/j.jsps.2015.07.001
Al-Turki DA, Al-Omar MA, Abou-Zeid LA, Shehata IA, Al-Awady MS. Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors. Saudi Pharm J. 2017 Jan;25(1):59-69. doi: 10.1016/j.jsps.2015.07.001. Epub 2015 Jul 26. PMID: 28223863; PMCID: PMC5310148.
Copy Download .nbib Format: NLM
Nocturnal enuresis: A topic review and institution experience.

Avicenna journal of medicine

DiBianco JM, Morley C, Al-Omar O.
PMID: 25506580
Avicenna J Med. 2014 Oct;4(4):77-86. doi: 10.4103/2231-0770.140641.

The objective is to provide a review of nocturnal enuresis (NE), including its epidemiology, etiology, pathophysiology, evaluation, and current management. We also set to provide further insight on the treatment of this condition from the experience derived from patients...

Cite
DiBianco JM, Morley C, Al-Omar O. Nocturnal enuresis: A topic review and institution experience. Avicenna J Med. 2014;4(4):77-86doi: 10.4103/2231-0770.140641.
DiBianco, J. M., Morley, C., & Al-Omar, O. (2014). Nocturnal enuresis: A topic review and institution experience. Avicenna journal of medicine, 4(4), 77-86. https://doi.org/10.4103/2231-0770.140641
DiBianco, John Michael, et al. "Nocturnal enuresis: A topic review and institution experience." Avicenna journal of medicine vol. 4,4 (2014): 77-86. doi: https://doi.org/10.4103/2231-0770.140641
DiBianco JM, Morley C, Al-Omar O. Nocturnal enuresis: A topic review and institution experience. Avicenna J Med. 2014 Oct;4(4):77-86. doi: 10.4103/2231-0770.140641. PMID: 25506580; PMCID: PMC4251068.
Copy Download .nbib Format: NLM
Continent urinary diversion with a urachal remnant.

Journal of pediatric urology

Al-Omar O, Fisher MB, McLorie GA.
PMID: 18947570
J Pediatr Urol. 2005 Oct;1(5):361-3. doi: 10.1016/j.jpurol.2005.02.001. Epub 2005 Apr 02.

The Mitrofanoff procedure, first described in 1980, has been widely adopted for pediatric continent urinary diversion to increase patient independence and continence, decrease morbidity and infections, and preserve renal function. Although this principle employs the appendix primarily, numerous other...

Cite
Al-Omar O, Fisher MB, McLorie GA. Continent urinary diversion with a urachal remnant. J Pediatr Urol. 2005;1(5):361-3doi: 10.1016/j.jpurol.2005.02.001.
Al-Omar, O., Fisher, M. B., & McLorie, G. A. (2005). Continent urinary diversion with a urachal remnant. Journal of pediatric urology, 1(5), 361-3. https://doi.org/10.1016/j.jpurol.2005.02.001
Al-Omar, Osama, et al. "Continent urinary diversion with a urachal remnant." Journal of pediatric urology vol. 1,5 (2005): 361-3. doi: https://doi.org/10.1016/j.jpurol.2005.02.001
Al-Omar O, Fisher MB, McLorie GA. Continent urinary diversion with a urachal remnant. J Pediatr Urol. 2005 Oct;1(5):361-3. doi: 10.1016/j.jpurol.2005.02.001. Epub 2005 Apr 02. PMID: 18947570.
Copy Download .nbib Format: NLM
Psoas abscess complicated by vesical fistula in a child managed by non-surgical therapy.

Journal of pediatric urology

Bandi G, Al-Omar O, McLorie GA.
PMID: 18947559
J Pediatr Urol. 2005 Aug;1(4):315-6. doi: 10.1016/j.jpurol.2005.01.009. Epub 2005 Mar 19.

We report an unusual case of a 2-year-old child with a psoas abscess fistulizing to the bladder, managed by non-surgical therapy including urethral catheter drainage, percutaneous abscess drainage and intravenous antibiotics.

Cite
Bandi G, Al-Omar O, McLorie GA. Psoas abscess complicated by vesical fistula in a child managed by non-surgical therapy. J Pediatr Urol. 2005;1(4):315-6doi: 10.1016/j.jpurol.2005.01.009.
Bandi, G., Al-Omar, O., & McLorie, G. A. (2005). Psoas abscess complicated by vesical fistula in a child managed by non-surgical therapy. Journal of pediatric urology, 1(4), 315-6. https://doi.org/10.1016/j.jpurol.2005.01.009
Bandi, Gaurav, et al. "Psoas abscess complicated by vesical fistula in a child managed by non-surgical therapy." Journal of pediatric urology vol. 1,4 (2005): 315-6. doi: https://doi.org/10.1016/j.jpurol.2005.01.009
Bandi G, Al-Omar O, McLorie GA. Psoas abscess complicated by vesical fistula in a child managed by non-surgical therapy. J Pediatr Urol. 2005 Aug;1(4):315-6. doi: 10.1016/j.jpurol.2005.01.009. Epub 2005 Mar 19. PMID: 18947559.
Copy Download .nbib Format: NLM
Quantification of the amphetamine content in seized street samples by Raman spectroscopy.

Journal of forensic sciences

Katainen E, Elomaa M, Laakkonen UM, Sippola E, Niemelä P, Suhonen J, Järvinen K.
PMID: 17209916
J Forensic Sci. 2007 Jan;52(1):88-92. doi: 10.1111/j.1556-4029.2006.00306.x.

A Raman spectroscopy method for determining the drug content of street samples of amphetamine was developed by dissolving samples in an acidic solution containing an internal standard (sodium dihydrogen phosphate). The Raman spectra of the samples were measured with...

Cite
Katainen E, Elomaa M, Laakkonen UM, et al. Quantification of the amphetamine content in seized street samples by Raman spectroscopy. J Forensic Sci. 2007;52(1):88-92doi: 10.1111/j.1556-4029.2006.00306.x.
Katainen, E., Elomaa, M., Laakkonen, U. M., Sippola, E., Niemelä, P., Suhonen, J., & Järvinen, K. (2007). Quantification of the amphetamine content in seized street samples by Raman spectroscopy. Journal of forensic sciences, 52(1), 88-92. https://doi.org/10.1111/j.1556-4029.2006.00306.x
Katainen, Erja, et al. "Quantification of the amphetamine content in seized street samples by Raman spectroscopy." Journal of forensic sciences vol. 52,1 (2007): 88-92. doi: https://doi.org/10.1111/j.1556-4029.2006.00306.x
Katainen E, Elomaa M, Laakkonen UM, Sippola E, Niemelä P, Suhonen J, Järvinen K. Quantification of the amphetamine content in seized street samples by Raman spectroscopy. J Forensic Sci. 2007 Jan;52(1):88-92. doi: 10.1111/j.1556-4029.2006.00306.x. PMID: 17209916.
Copy Download .nbib Format: NLM
Bi-3H-diazirin-3-yls as precursors of highly strained cycloalkynes.

Angewandte Chemie (International ed. in English)

Al-Omari M, Banert K, Hagedorn M.
PMID: 16372311
Angew Chem Int Ed Engl. 2005 Dec 23;45(2):309-11. doi: 10.1002/anie.200503124.

No abstract available.

Cite
Al-Omari M, Banert K, Hagedorn M. Bi-3H-diazirin-3-yls as precursors of highly strained cycloalkynes. Angew Chem Int Ed Engl. 2005;45(2):309-11doi: 10.1002/anie.200503124.
Al-Omari, M., Banert, K., & Hagedorn, M. (2005). Bi-3H-diazirin-3-yls as precursors of highly strained cycloalkynes. Angewandte Chemie (International ed. in English), 45(2), 309-11. https://doi.org/10.1002/anie.200503124
Al-Omari, Mohammad, et al. "Bi-3H-diazirin-3-yls as precursors of highly strained cycloalkynes." Angewandte Chemie (International ed. in English) vol. 45,2 (2005): 309-11. doi: https://doi.org/10.1002/anie.200503124
Al-Omari M, Banert K, Hagedorn M. Bi-3H-diazirin-3-yls as precursors of highly strained cycloalkynes. Angew Chem Int Ed Engl. 2005 Dec 23;45(2):309-11. doi: 10.1002/anie.200503124. PMID: 16372311.
Copy Download .nbib Format: NLM
How accurate are fecal tests for determination of cure after Helicobacter pylori eradication therapy?.

Nature clinical practice. Gastroenterology & hepatology

McNamara D, El-Omar EM.
PMID: 17375055
Nat Clin Pract Gastroenterol Hepatol. 2007 May;4(5):248-9. doi: 10.1038/ncpgasthep0790.

No abstract available.

Cite
McNamara D, El-Omar EM. How accurate are fecal tests for determination of cure after Helicobacter pylori eradication therapy?. Nat Clin Pract Gastroenterol Hepatol. 2007;4(5):248-9doi: 10.1038/ncpgasthep0790.
McNamara, D., & El-Omar, E. M. (2007). How accurate are fecal tests for determination of cure after Helicobacter pylori eradication therapy?. Nature clinical practice. Gastroenterology & hepatology, 4(5), 248-9. https://doi.org/10.1038/ncpgasthep0790
McNamara, Deirdre, and El-Omar, Emad M. "How accurate are fecal tests for determination of cure after Helicobacter pylori eradication therapy?." Nature clinical practice. Gastroenterology & hepatology vol. 4,5 (2007): 248-9. doi: https://doi.org/10.1038/ncpgasthep0790
McNamara D, El-Omar EM. How accurate are fecal tests for determination of cure after Helicobacter pylori eradication therapy?. Nat Clin Pract Gastroenterol Hepatol. 2007 May;4(5):248-9. doi: 10.1038/ncpgasthep0790. PMID: 17375055.
Copy Download .nbib Format: NLM
Ethyl 2-amino-4-(4-bromo-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate.

Acta crystallographica. Section E, Structure reports online

El-Agrody AM, Fouda AM, Al-Omar MA, Amr Ael-G, Ng SW, Tiekink ER.
PMID: 23476606
Acta Crystallogr Sect E Struct Rep Online. 2013 Mar 01;69:o435-6. doi: 10.1107/S160053681300490X. Epub 2013 Feb 23.

In the title compound, C23H20BrNO4, the pyran ring has a flattened boat conformation with the O and methine C atoms lying to one side of the plane [0.160 (5) and 0.256 (6) Å, respectively] defined by the remaining atoms....

Cite
El-Agrody AM, Fouda AM, Al-Omar MA, et al. Ethyl 2-amino-4-(4-bromo-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online. 2013;69:o435-6doi: 10.1107/S160053681300490X.
El-Agrody, A. M., Fouda, A. M., Al-Omar, M. A., Amr, A. e. l. -. G., Ng, S. W., & Tiekink, E. R. (2013). Ethyl 2-amino-4-(4-bromo-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online, 69o435-6. https://doi.org/10.1107/S160053681300490X
El-Agrody, Ahmed M, et al. "Ethyl 2-amino-4-(4-bromo-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate." Acta crystallographica. Section E, Structure reports online vol. 69 (2013): o435-6. doi: https://doi.org/10.1107/S160053681300490X
El-Agrody AM, Fouda AM, Al-Omar MA, Amr Ael-G, Ng SW, Tiekink ER. Ethyl 2-amino-4-(4-bromo-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online. 2013 Mar 01;69:o435-6. doi: 10.1107/S160053681300490X. Epub 2013 Feb 23. PMID: 23476606; PMCID: PMC3588478.
Copy Download .nbib Format: NLM
3-(Adamantan-1-yl)-4-methyl-1-[(4-phenyl-piperazin-1-yl)meth-yl]-1H-1,2,4-triazole-5(4H)-thione dichloro-methane hemisolvate.

Acta crystallographica. Section E, Structure reports online

El-Emam AA, Al-Omar MA, Al-Tamimi AM, Ng SW, Tiekink ER.
PMID: 22719551
Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 01;68:o1772-3. doi: 10.1107/S1600536812021393. Epub 2012 May 19.

The asymmetric unit of the title dichloro-methane hemisolvate, C(24)H(33)N(5)S·0.5CH(2)Cl(2), comprises an adamantan-yl/triazole derivative and half a CH(2)Cl(2) mol-ecule of crystallization; the latter is disordered about a twofold axis of symmetry. The piperazine ring has a chair conformation and the...

Cite
El-Emam AA, Al-Omar MA, Al-Tamimi AM, et al. 3-(Adamantan-1-yl)-4-methyl-1-[(4-phenyl-piperazin-1-yl)meth-yl]-1H-1,2,4-triazole-5(4H)-thione dichloro-methane hemisolvate. Acta Crystallogr Sect E Struct Rep Online. 2012;68:o1772-3doi: 10.1107/S1600536812021393.
El-Emam, A. A., Al-Omar, M. A., Al-Tamimi, A. M., Ng, S. W., & Tiekink, E. R. (2012). 3-(Adamantan-1-yl)-4-methyl-1-[(4-phenyl-piperazin-1-yl)meth-yl]-1H-1,2,4-triazole-5(4H)-thione dichloro-methane hemisolvate. Acta crystallographica. Section E, Structure reports online, 68o1772-3. https://doi.org/10.1107/S1600536812021393
El-Emam, Ali A, et al. "3-(Adamantan-1-yl)-4-methyl-1-[(4-phenyl-piperazin-1-yl)meth-yl]-1H-1,2,4-triazole-5(4H)-thione dichloro-methane hemisolvate." Acta crystallographica. Section E, Structure reports online vol. 68 (2012): o1772-3. doi: https://doi.org/10.1107/S1600536812021393
El-Emam AA, Al-Omar MA, Al-Tamimi AM, Ng SW, Tiekink ER. 3-(Adamantan-1-yl)-4-methyl-1-[(4-phenyl-piperazin-1-yl)meth-yl]-1H-1,2,4-triazole-5(4H)-thione dichloro-methane hemisolvate. Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 01;68:o1772-3. doi: 10.1107/S1600536812021393. Epub 2012 May 19. PMID: 22719551; PMCID: PMC3379353.
Copy Download .nbib Format: NLM
Ethyl 2-amino-4-(4-fluoro-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate.

Acta crystallographica. Section E, Structure reports online

El-Agrody AM, Al-Omar MA, Amr AG, Chia TS, Fun HK.
PMID: 22719576
Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 01;68:o1803-4. doi: 10.1107/S1600536812021939. Epub 2012 May 19.

In the title compound, C(23)H(20)FNO(4), the fluoro-substituted benzene ring is approximately perpendicular to the mean plane of the 4H-benzo[h]chromene ring system [maximum deviation = 0.264 (1) Å], with a dihedral angle of 83.79 (6)°. The pyran ring adopts a...

Cite
El-Agrody AM, Al-Omar MA, Amr AG, et al. Ethyl 2-amino-4-(4-fluoro-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online. 2012;68:o1803-4doi: 10.1107/S1600536812021939.
El-Agrody, A. M., Al-Omar, M. A., Amr, A. G., Chia, T. S., & Fun, H. K. (2012). Ethyl 2-amino-4-(4-fluoro-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online, 68o1803-4. https://doi.org/10.1107/S1600536812021939
El-Agrody, Ahmed M, et al. "Ethyl 2-amino-4-(4-fluoro-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate." Acta crystallographica. Section E, Structure reports online vol. 68 (2012): o1803-4. doi: https://doi.org/10.1107/S1600536812021939
El-Agrody AM, Al-Omar MA, Amr AG, Chia TS, Fun HK. Ethyl 2-amino-4-(4-fluoro-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 01;68:o1803-4. doi: 10.1107/S1600536812021939. Epub 2012 May 19. PMID: 22719576; PMCID: PMC3379378.
Copy Download .nbib Format: NLM
5-Chloro-2-methyl-sulfonyl-1,2,4-triazolo[1,5-a]quinazoline.

Acta crystallographica. Section E, Structure reports online

Al-Salahi R, Al-Omar M, Marzouk M, Ng SW.
PMID: 22719581
Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 01;68:o1809. doi: 10.1107/S1600536812021770. Epub 2012 May 19.

The triazoloquinazole fused-ring system of the title compound, C(10)H(7)ClN(4)O(2)S, is essentially planar (r.m.s. deviation = 0.009 Å). In the methyl-sulfonyl substituent, the two S-O bonds are of equal length [1.402 (2) Å]. In the crystal, adjacent mol-ecules inter-act weakly...

Cite
Al-Salahi R, Al-Omar M, Marzouk M, et al. 5-Chloro-2-methyl-sulfonyl-1,2,4-triazolo[1,5-a]quinazoline. Acta Crystallogr Sect E Struct Rep Online. 2012;68:o1809doi: 10.1107/S1600536812021770.
Al-Salahi, R., Al-Omar, M., Marzouk, M., & Ng, S. W. (2012). 5-Chloro-2-methyl-sulfonyl-1,2,4-triazolo[1,5-a]quinazoline. Acta crystallographica. Section E, Structure reports online, 68o1809. https://doi.org/10.1107/S1600536812021770
Al-Salahi, Rashad, et al. "5-Chloro-2-methyl-sulfonyl-1,2,4-triazolo[1,5-a]quinazoline." Acta crystallographica. Section E, Structure reports online vol. 68 (2012): o1809. doi: https://doi.org/10.1107/S1600536812021770
Al-Salahi R, Al-Omar M, Marzouk M, Ng SW. 5-Chloro-2-methyl-sulfonyl-1,2,4-triazolo[1,5-a]quinazoline. Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 01;68:o1809. doi: 10.1107/S1600536812021770. Epub 2012 May 19. PMID: 22719581; PMCID: PMC3379383.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 191 entries